What is the probability that a urinary tract infection is the cause of gross hematuria in a 72-year-old man with negative leukocytes and nitrites on urinalysis, who was started on nitrofurantoin (Macrobid) and whose hematuria has improved, with no other urinary symptoms, no costovertebral angle tenderness, no family history of prostate, bladder, or renal cancer, and who is a non‑smoker?

The Probability of UTI is Low in This Case

Given the negative leukocyte esterase and nitrites on urinalysis, the probability that UTI is the true cause of this patient's gross hematuria is very low (<10-20%), and this 72-year-old man requires urgent urologic evaluation regardless of the improvement on nitrofurantoin. 1

Critical Clinical Context

This presentation raises significant red flags that demand immediate attention:

Why UTI is Unlikely Here

• Negative pyuria markers: The absence of both leukocyte esterase AND nitrites on dipstick testing has a 95% negative predictive value for UTI 2. When both are negative, UTI is highly improbable
• Isolated gross hematuria: In older males, painless gross hematuria without dysuria, frequency, urgency, or CVA tenderness is a classic presentation of urothelial malignancy, not infection 1, 3
• Age and gender: At 72 years old and male, this patient falls into a high-risk category where gross hematuria carries a >10-25% probability of underlying genitourinary cancer 1

The Improvement on Macrobid is a Red Herring

The clinical improvement after starting nitrofurantoin does not confirm UTI as the diagnosis. Here's why:

• Spontaneous resolution: Gross hematuria from various causes (including malignancy) can be intermittent and self-limited 1
• Temporal coincidence: The timing may be coincidental rather than causative
• Hematuria from UTI typically has pyuria: True hemorrhagic UTI would be expected to show positive leukocyte esterase and/or nitrites 4, 5

Mandatory Next Steps

This patient requires urgent urology referral for cystoscopy and imaging (CT urography or MRI urography), even though the hematuria has improved. 1

The American College of Physicians guidelines are unequivocal:

• High-Value Care Advice 4: "Clinicians should refer for further urologic evaluation in all adults with gross hematuria, even if self-limited" 1
• This recommendation applies regardless of anticoagulation status, presumed benign causes, or clinical improvement 1

The Evaluation Cannot Be Deferred

• Cancer risk: Studies consistently show that patients >40 years with gross hematuria have significant rates of genitourinary malignancy (10-25% in referral series) 1, 3
• Microscopic hematuria threshold: Even patients with ≥3 RBCs/HPF on microscopy warrant consideration for urologic evaluation; gross hematuria mandates it 1
• No benign cause identified: The negative UA for infection markers means no demonstrable benign cause has been established 1

Clinical Pitfalls to Avoid

1. Do not assume antibiotics "cured" the problem: The improvement could represent natural fluctuation of hematuria from any cause, including malignancy
2. Do not recheck UA and wait: While one study suggests waiting 12 weeks to retest UA after UTI treatment 6, this applies to confirmed UTI cases with pyuria—not this scenario
3. Do not be falsely reassured by negative family history: Most bladder and renal cancers are sporadic, not familial
4. Do not delay because he's a non-smoker: While smoking is a major risk factor, age >70 alone places him at substantial risk 1

Bottom Line

The probability that UTI explains this presentation is less than 20% based on the negative urinalysis markers. This patient needs cystoscopy and upper tract imaging urgently to rule out malignancy, which carries a probability of 10-25% in this demographic with gross hematuria. The clinical improvement on antibiotics should not delay this evaluation.